Nitroglycerin topical - PUMC PharmaceuticalAlternative Names: Ruituoxi
Latest Information Update: 26 Nov 2015
At a glance
- Originator Cellegy Pharmaceuticals
- Developer PUMC Pharmaceutical Company
- Class Erectile dysfunction therapies; Heart failure therapies; Ischaemic heart disorder therapies; Nitro compounds; Organic nitrates; Small molecules; Sugar alcohols; Vasodilators
- Mechanism of Action Nitric oxide donors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preregistration Fissure in ano
Most Recent Events
- 15 Mar 2016 Biomarkers information updated